IBT
RGEN icon

International Biotechnology Trust’s Repligen RGEN Stock Holding History

International Biotechnology Trust’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-24,000
Closed -$1.84M – 64
2019
Q3 		$1.84M Hold
24,000
– – 0.85% 27
2019
Q2 		$2.06M Buy
+24,000
New +$1.64M 0.76% 35

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

International Biotechnology Trust's RGEN Position: Q4 2019 in Review

International Biotechnology Trust sold out of Repligen (RGEN) in Q4 2019, closing a stake of 24,000 shares — an estimated $1.84M sold.

International Biotechnology Trust first reported a position in RGEN in Q2 2019 and held it in 2 quarters. The position peaked at $2.06M in Q2 2019. 306 funds tracked by Wall St. Rank hold RGEN as of Q4 2019.

  • International Biotechnology Trust reported no remaining Repligen position as of Q4 2019 after selling out during the quarter.
  • International Biotechnology Trust sold 24,000 Repligen shares in Q4 2019, an estimated $1.84M.
  • International Biotechnology Trust first reported a position in Repligen in Q2 2019 and held it in 2 quarters.
  • International Biotechnology Trust's Repligen position peaked at $2.06M in Q2 2019.
  • 306 funds tracked by Wall St. Rank held Repligen as of Q4 2019.

Based on International Biotechnology Trust's 13F filing for Q4 2019, filed 18 May 2020.